We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$118M
This Fund
S&P 500
This Quarter
Est. Return
+5.45%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$180M
AUM Growth
+$35.3M
(+24%)
Cap. Flow
+$33.3M
Cap. Flow
% of AUM
18.49%
Top 10 Holdings %
Top 10 Hldgs %
21.58%
Holding
287
New
78
Increased
46
Reduced
73
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$4.54M |
| 2 |
Coherus Oncology
CHRS
|
+$3.29M |
| 3 |
Amylyx Pharmaceuticals
AMLX
|
+$2.71M |
| 4 |
Embecta
EMBC
|
+$2.55M |
| 5 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$2.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$4.1M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.81M |
| 3 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.81M |
| 4 |
Innoviva
INVA
|
+$2.07M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$1.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 59.9% |
| 2 | Real Estate | 10.66% |
| 3 | Financials | 4.01% |
| 4 | Technology | 3.46% |
| 5 | Consumer Discretionary | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Enphase Energy
ENPH
$4.84B
| $26.8K | 0.01% |
160
-6
| -4% | -$1.07K |
|
227
AbbVie
ABBV
$458B
| – | – |
-1,679
| Closed | -$268K |
|
228
AutoNation
AN
$6.97B
| – | – |
-835
| Closed | -$112K |
|
|
229
Bio-Rad Laboratories Class A
BIO
$8.42B
| – | – |
-3,400
| Closed | -$1.63M |
|
230
Builders FirstSource
BLDR
$7.84B
| – | – |
-1,545
| Closed | -$137K |
|
231
BioXcel Therapeutics
BTAI
$26.2M
| – | – |
-2,500
| Closed | -$746K |
|
232
Avis
CAR
$5.63B
| – | – |
-504
| Closed | -$98.2K |
|
233
Cleveland-Cliffs
CLF
$6.81B
| – | – |
-4,758
| Closed | -$87.2K |
|
234
Cencora
COR
$60.3B
| – | – |
-1,652
| Closed | -$265K |
|
235
CVS Health
CVS
$137B
| – | – |
-1,281
| Closed | -$95.2K |
|
236
DocGo
DCGO
$58.9M
| – | – |
-120,000
| Closed | -$1.04M |
|
237
Datadog
DDOG
$87.9B
| – | – |
-474
| Closed | -$34.4K |
|
238
Dow Inc
DOW
$21.6B
| – | – |
-1,930
| Closed | -$106K |
|
239
iShares MSCI Philippines ETF
EPHE
$127M
| – | – |
-289
| Closed | -$7.79K |
|
240
General Mills
GIS
$19.2B
| – | – |
-3,495
| Closed | -$299K |
|
241
HP
HPQ
$23.5B
| – | – |
-3,417
| Closed | -$100K |
|
242
InMode
INMD
$872M
| – | – |
-27,000
| Closed | -$863K |
|
|
243
Innoviva
INVA
$1.58B
| – | – |
-184,000
| Closed | -$2.07M |
|
|
K
244
DELISTED
Kellanova
K
| – | – |
-3,776
| Closed | -$237K |
|
245
Coca-Cola
KO
$354B
| – | – |
-3,892
| Closed | -$241K |
|
246
Knightscope
KSCP
$25M
| – | – |
-10,000
| Closed | -$445K |
|
247
LyondellBasell Industries
LYB
$19.5B
| – | – |
-1,247
| Closed | -$117K |
|
248
MetLife
MET
$61B
| – | – |
-1,977
| Closed | -$115K |
|
|
MMD
249
MainStay MacKay DefinedTerm Municipal Opportunities Fund
MMD
$283M
| – | – |
-11,242
| Closed | -$195K |
|
250
Monolithic Power Systems
MPWR
$65.5B
| – | – |
-120
| Closed | -$60.1K |
|
Similar funds
AIS
IVGAI
OIM
TIP
RCG
CWM
SPW
WLC
AlphaCentric Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, AlphaCentric Advisors held 287 positions worth $180M, up 24% from $145M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
AlphaCentric Advisors deployed $33.3M of net new capital in Q2 2023, opening 78 new positions and adding to 46 existing holdings. Its largest new stake was Embecta: 93,500 shares worth $2.02M.
By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 56% a quarter earlier, followed by Real Estate and Financials.
On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $4.1M trimmed.
- AlphaCentric Advisors's largest Q2 2023 buy was Embecta: 93,500 shares worth $2.02M.
- AlphaCentric Advisors added most to Jazz Pharmaceuticals in Q2 2023, an estimated $4.54M increase.
- AlphaCentric Advisors's biggest Q2 2023 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $4.1M.
- AlphaCentric Advisors fully exited Invesco QQQ Trust in Q2 2023, selling an estimated $2.81M.
- AlphaCentric Advisors's ten largest holdings make up 22% of its $180M portfolio in Q2 2023.
- AlphaCentric Advisors opened 78 new positions and closed 55 in Q2 2023.
- AlphaCentric Advisors's portfolio value rose 24% quarter-over-quarter to $180M.
Based on AlphaCentric Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.